Studies on immune serum globulin (IgG) and its modification for intravenous administration.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D007611:Aprotinin / Q000494:pharmacology; D002845:Chromatography; D004355:Drug Stability; D004356:Drug Storage; D005341:Fibrinolysin / Q000032:analysis; D006168:Guinea Pigs; D006851:Hydrochloric Acid; D006863:Hydrogen-Ion Concentration; D007106:Immune Sera / Q000032:analysis*; D007112:Immunity, Maternally-Acquired; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000032:analysis* / Q000378:metabolism / Q000627:therapeutic use; D007275:Injections, Intravenous; D008457:Measles / Q000517:prevention & control; D010447:Peptide Hydrolases / Q000378:metabolism; D013744:Tetanus Toxin; D014238:Trichloroacetic Acid; D014461:Ultracentrifugation
D000614:Aminocaproates; D000906:Antibodies; D007106:Immune Sera; D007074:Immunoglobulin G; D013744:Tetanus Toxin; D014238:Trichloroacetic Acid; D007611:Aprotinin; D010447:Peptide Hydrolases; D005341:Fibrinolysin; D006851:Hydrochloric Acid